Cogley Brian 4

4 · Coeptis Therapeutics Holdings, Inc. · Filed Mar 6, 2025

Insider Transaction Report

Form 4
Period: 2025-03-04
Cogley Brian
Chief Financial Officer
Transactions
  • Award

    Non-Qualified Stock Options (right to buy)

    2025-03-04+10,00022,500 total
    Exercise: $10.56Common Stock (10,000 underlying)
Footnotes (4)
  • [F1]On March 4, 2025, the reporting person received a grant of 10,000 non-qualified stock options, under the 2022 equity incentive plan.
  • [F2]The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant.
  • [F3]Options will vest over 4 years, in equal quarterly installments over such period, with the final options vesting on 12/31/28.
  • [F4]Expiration date is ten years from the day of grant.

Documents

1 file
  • 4
    ownership.xmlPrimary